Outlook Therapeutics, Inc. · NASDAQ:OTLK
Haddadin Yezan Munther bought 29,000 Outlook Therapeutics, Inc. shares (Form 4)
Traded Jun 2, 2026 · Filed Jun 3, 2026
On Jun 2, 2026, Haddadin Yezan Munther (Director) bought 29,000 Outlook Therapeutics, Inc. shares at US$0.83 for US$24,070, leaving 66,167 shares. Filed Jun 3, 2026 (Form 4).
- Bought
- 29,000 shares
- Price
- US$0.83
- Value
- US$24,070
- Holding after
- 66,167 shares
- Trading plan
- No
- Role
- Director
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Jun 2, 2026 | Common Stock | Buy | 29,000 | US$0.83 | 66,167 | Direct |
Source
Related
- Outlook Therapeutics, Inc.
- Haddadin Yezan Munther
- Outlook Therapeutics, Inc. shareholders
- Form 4 · Haddadin Yezan Munther · May 27, 2026
- Schedule 13G · Empery Asset Management, LP · Oct 13, 2026
- Schedule 13G · CVI Investments, Inc. · Aug 19, 2026
- Form 4 · Jahr Robert Charles · Aug 14, 2026
- Form 4 · Kenyon Lawrence A · Aug 14, 2026
- Form 4 · Sukhtian Ghiath M. · Aug 14, 2026